Tropic Biosciences Competitors and Similar CompaniesClear all

Tropic Biosciences's competitors and similar companies include ChargePoint Technology, Novavax, Phasefocus and SEPPURE.

	Tropic Biosciences Tropic Biosciences is a biotechnology company that uses advanced plant breeding and gene editing technologies to develop commercial tropical crops such as coffee, rice, and bananas.	ChargePoint Technology ChargePoint Technology is a company developing split butterfly containment valves and docking systems.	Novavax Novavax is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases.	Phasefocus Phasefocus is a company offering lensless microscopy technology for radar, ultra-violet and infra-red imaging, and terahertz imaging applications.	SEPPURE SEPPURE develops sustainable nano-filtration solutions intended to separate chemical mixtures at a molecular level with minimal energy use.
Founding Date	Founding Date 2016	Founding Date 2009	Founding Date 1987	Founding Date 2006	Founding Date 2018
Type	Type Private	Type Private	Type Public	Type Private	Type Private
Tags	Tags Technology agricultural products agritech biotech	Tags Manufacturing & Industrial Technology biotech pharma	Tags Healthcare Manufacturing & Industrial Technology biotech healthtech pharma	Tags Manufacturing & Industrial Technology biotech imaging optics	Tags Manufacturing & Industrial Technology biotech chemicals nanotech
Locations	Locations Norfolk, GB HQ	Locations Speke, GB HQ Lacey Township, US	Locations Gaithersburg, US HQ Jevany, CZ Uppsala, SE Rockville, US	Locations Sheffield, GB HQ London, GB	Locations Singapore, SG HQ Calgary, CA Singapore, SG
Employees	Employees 164	Employees 1212% increase	Employees 16845% decrease	Employees 9	Employees 38
Financial
Revenue (est.)	Revenue (est.) £730.1k (FY, 2023)	Revenue (est.) N/A	Revenue (est.) $1.1b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods £424.5k (FY, 2023)	Cost of goods N/A	Cost of goods $73m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit £305.6k (FY, 2023)	Gross profit N/A	Gross profit $1.1b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income (£14.8m) (FY, 2023)	Net income N/A	Net income $440.3m (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round $ 28.5m (almost 6 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 5m (almost 14 years ago)	Latest funding round $ 2.6m (over 6 years ago)
Total funding raised	Total funding raised $ 38.5m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 6.8m	Total funding raised $ 2.8m